By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Svyazi Street., 34-A

Saint-Petersburg  Strelna    Russia
Phone: +7-812-380-49-33 Fax: +7-812-380-49-34



Company News
BioCad’s Rituximab Biosimilar To Receive MA Soon In India 7/5/2017 6:41:39 AM
BioCad Registered The First Rituximab Biosimilar In Bolivia And Honduras 6/5/2017 6:56:46 AM
BioCad Joins The EU 5/25/2017 6:16:06 AM
BioCad Keeps On Supplying Its Medicine For Blood Cancer Treatment In Vietnam 3/30/2017 6:28:19 AM
BioCad: The First Ever Biosimilar Of Interferon Beta-1a Approved In Russia 3/3/2017 6:33:29 AM
BioCad: Advanced Rheumatoid Arthritis Medicine Developed In Russia 7/11/2016 9:46:32 AM
BioCad Started Exports Of Pharmaceuticals To Sri Lanka 3/30/2016 10:55:25 AM
BioCad Release: Innovative Russian Medicine Mobilizes Human Immune System To Fight Cancer 3/23/2016 9:51:36 AM
BioCad Scores Another Victory In mAb Biosimilars With Marketing Authorization For Bevacizumab 12/10/2015 6:58:35 AM
BioCad Release: Russian Biotechnological Company Won The Case Against Big Pharma On The Patent Dispute Notable For The Pharmaceutical Industry 11/3/2015 7:22:10 AM